News
Regeneron Pharmaceuticals’ shares closed up 2.7% to $587.65 as it announced that the primary and key secondary endpoints were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback